Press Releases

Active Biotech AB Year-end report January - December 2017
February 15, 2018 08:30 (CET)
Regulatory
Active Biotech provides updated information about the company's financial position
December 20, 2017 15:00 (CET)
Regulatory
Active Biotech provides updated information about the company's financial position - the company currently lacks funding to ensure its operations for the coming twelve-month period
December 7, 2017 19:00 (CET)
Regulatory
Active Biotech announce results in ARPEGGIO Phase II trial with laquinimod in Primary Progressive MS
December 1, 2017 13:00 (CET)
Regulatory
Active Biotech's election committee appointed
November 17, 2017 08:30 (CET)
Active Biotech AB - Interim report January - September 2017
November 9, 2017 08:30 (CET)
Regulatory
Active Biotech's partner Teva presents new data on laquinimod for the treatment of multiple sclerosis at 7th joint ECTRIMS-ACTRIMS Meeting
October 19, 2017 14:00 (CEST)
Active Biotech AB - Interim report January - June 2017
August 10, 2017 08:30 (CEST)
Regulatory
Helén Tuvesson new CEO of Active Biotech AB from July 1, 2017
June 19, 2017 15:30 (CEST)
Regulatory
Annual General Meeting of Active Biotech AB
June 16, 2017 08:30 (CEST)
Regulatory